Original Research

Page 4

Posts about this type

JCP
Smoking in Borderline Patients
Original Research

November 8, 2023

This study assessed predictors of smoking in borderline personality disorder and compared smoking prevalence in recovered vs non-recovered patients.
Marcelo J. A. A. Brañas, Frances R. Frankenburg, Christina M. Temes, et al
JCP
Medication Adherence in a Transdiagnostic FEP Sample
Original Research

November 1, 2023

Thirty percent of patients with first-episode psychosis showed non-adherence to medication over a period of up to 5½ years. Treatment factors such as the type or dose of antipsychotic...
Stephanie M. London, Philip B. Cawkwell, Ann K. Shinn
JCP
Training for Lasting Trauma-Informed Change
Original Research

October 30, 2023

Two-day training in trauma-informed care (TIC) significantly improved understanding and implementation of TIC at both the individual and systemwide levels.
Alexandra R. Mangus, E. Kate Webb, Miri Bar-Halpern, et al
JCP
Heated Yoga for Depression
Original Research

October 23, 2023

Approximately 1 heated yoga session per week for 8 weeks led to significantly greater reduction in depression symptoms than a waitlist control.
Maren B. Nyer, Lindsey B. Hopkins, Megha Nagaswami, et al
PCC
Topiramate for Civilian PTSD
Original Research

October 19, 2023

The results for anticonvulsants in the treatment of PTSD have been mixed. This study investigated the efficacy and safety of the anticonvulsant agent topiramate for the treatment of civilian...
Varun Monga, Frederick Petty, Kalpana Padala, et al
JCP
Adult Outcomes of Children With Reactive Attachment Disorder
Original Research

October 18, 2023

Adults who had reactive attachment disorder as children had high rates of psychiatric diagnoses, substance use, suicide attempts, and psychiatric hospitalizations.
Hannah K. Betcher, Tanner J. Bommersbach, Bruno A. Perossa, et al
PCC
Association of Khat Use Disorder and Antisocial Personality Disorder Among Inmates
Original Research

October 17, 2023

This study examined the relationship between khat use disorder and antisocial personality disorder in newly admitted inmates in a correctional facility in Ethiopia.
Asrat Wolde, Chalachew Kassaw, Selamawit Alemayehu Tessema
JCP
Obsessive-Compulsive Symptoms and Psychosis Risk
Original Research

image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ October 16, 2023

Among youth at clinical high risk for psychosis, obsessive-compulsive symptoms had a high prevalence (50%) and were associated with a more severe clinical and functional profile.
Laura Vergara, Elena de la Serna, Gisela Sugranyes, et al
JCP
Solriamfetol for ADHD in Adults
Original Research

October 9, 2023

Some individuals with attention-deficit/hyperactivity disorder (ADHD) may not tolerate or adequately respond to currently available treatments. This study examined the efficacy and tolerability of solriamfetol in the treatment for...
Craig B. H. Surman, Daniel M. Walsh, Nora Horick, et al
PCC
Post-COVID Lung Dysfunction and New-Onset Anxiety and Depression
Original Research

October 5, 2023

Incentive spirometry, in addition to providing gains in pulmonary function, improved new-onset anxiety and depressive symptoms in post-COVID patients.
Kiran Kumar Gudivada, Sai Krishna Tikka, Yashwanth Bonthala, et al
JCP
Celecoxib Augmentation of Vortioxetine for Cognition in MDD
Original Research

October 4, 2023

Anti-inflammatory augmentation of vortioxetine did not provide additional benefit in reducing cognitive symptoms of MDD.
Emma Sampson, Natalie T. Mills, Hikaru Hori, et al
PCC
Psychiatric Comorbidities of Neurofibromatosis
Original Research

October 3, 2023

Neurofibromatosis is a group of inherited neurocutaneous disorders that includes neurofibromatosis types 1 and 2 and schwannomatosis. This study assessed the prevalence of psychiatric comorbidities in patients with neurofibromatosis.
Kanwarjeet S. Brar, Chintan Trivedi, Navdeep Kaur, et al
JCP
Lemborexant and Daridorexant in Insomnia: NNT, NNH, and LHH
Original Research

October 2, 2023

This study examined whether differences existed between lemborexant and daridorexant in number needed to treat (NNT), number needed to harm (NNH), and likelihood to be helped or harmed (LHH)...
Leslie Citrome, Timothy R. Juday, Christie Lundwall
JCP
Earlier Use of Paliperidone Palmitate in Patients With Schizophrenia
Original Research

September 25, 2023

Long-acting injectable antipsychotics (LAIs) are typically reserved for patients with a long history of schizophrenia. This analysis of 3 studies found benefit in initiating the LAI paliperidone palmitate earlier...
Oliver J. Lopena, Larry D. Alphs, Martha Sajatovic, et al
JCP
Amyotrophic Lateral Sclerosis and Suicide Attempts
Original Research

September 20, 2023

The common risk factors for suicide attempts may not directly apply to patients with amyotrophic lateral sclerosis (ALS) due to their group-specific characteristics. This study aimed to identify risk...
Hyung Keun Park, Seok-Jin Choi, Ye-Jee Kim, et al
PCC
Mental Health of Hospital Staff During COVID
Original Research

September 19, 2023

Psychological morbidities during the second wave of the COVID-19 pandemic were significantly higher among nurses compared to other hospital staff.
N. A. Uvais, Mohammed Jezeel Nalakath
JCP
THC for Neuropsychiatric Symptoms of Dementia
Original Research

September 18, 2023

Neuropsychiatric symptoms (NPS) in dementia are challenging to manage, and available treatments have a significant side effect profile. This study evaluated the effectiveness of dispensary-obtained tetrahydrocannabinol for patients with...
Samantha M. Sawicki, Cristian Hernandez, Neda Laiteerapong, et al
JCP
Excess Mortality Associated With Schizophrenia
Original Research

September 13, 2023

Females, patients with connective tissue disorders, and those aged 20 years or younger were especially impacted by the effect of schizophrenia on increasing mortality.
Chih-Ming Cheng, Wen-Han Chang, Shih-Jen Tsai, et al
PCC
Assessment of Sleep in Medical Trainees
Original Research

September 12, 2023

This study assessed the prevalence of sleep disturbance among medical trainees during their clinical years, as well as associations with night versus day shifts, psychological stress, and fatigue.
Sana Chahine, Jad Kassem, Samira Wanna, et al
JCP
Coprescribing of Z-Drugs and Opioids During COVID-19
Original Research

September 11, 2023

Coprescribing of nonbenzodiazepine sedative-hypnotics, or “Z-drugs,” with opioids was more common among older patients, although the odds of coprescription among patients overall decreased over the COVID-19 lockdown period.
Akhil Anand, Jeremy Weleff, Nicolas R. Thompson, et al
JCP
Mortality Within 1 Year After Suicide Attempt
Original Research

September 11, 2023

One in 100 people who attempted suicide died by suicide within 1 year; men aged 45 years or older were at greater risk than other demographic groups.
Alice Demesmaeker, Ali Amad, Emmanuel Chazard, et al
JCP
Risk-Sensitive Decision-Making and Self-Harm
Original Research

September 6, 2023

Greater risk-taking has been associated with suicide attempts in youth with major depression. This study examined whether the association between self-harm and risk-sensitive decision-making is true for bipolar disorder...
Mikaela K. Dimick, Alysha A. Sultan, Kody G. Kennedy, et al
JCP
Safety and Efficacy of Aripiprazole 2-Month Ready-to-Use 960 mg
Original Research

September 4, 2023

A new formulation of injectable aripiprazole for administration every 2 months showed similar rates of treatment-emergent adverse events to aripiprazole once-monthly 400 mg. Patients in both groups remained clinically...
Leslie Citrome, Pedro Such, Murat Yildirim, et al
PCC
Benztropine Usage Patterns in Movement Disorders
Original Research

August 29, 2023

This study evaluated real-world treatment patterns for patients initiating benztropine and examined treatment approaches in patients with drug-induced movement disorders from a health care provider perspective.
Craig Chepke, Betsy Benning, Samantha Cicero, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe